Is Immuneering Corporation overvalued?

Immuneering Corporation (IMRX) — key valuation metrics and fundamentals.

No verdict

Price

$3.71

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$240.3M

Dividend yield

0.0%

Return on equity

-33.9%

Sector

Healthcare

Fair value compares IMRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks